Search - tctmd.com

Displaying 181 - 190 of 190

Sort: Relevancy | Date

News Conference News

Complications After TAVR: Manageable, But Important to Consider

November 09, 2011

News Conference News

TAVR Bioprosthesis Safe, Effective at 1 Year

November 07, 2011

News Industry News

Study Shows Medtronic CoreValve® System Efficacy and Durability Through Four Years in Longest-Term Industry Data Available

August 28, 2011

News Industry News

St. Jude Medical Announces FDA Approval of Trifecta Valve

April 20, 2011

News Daily News

TAVI with CoreValve Effective, Safe at 2-Years, Though Mortality a Concern

Leah Lawrence

April 11, 2011

News Daily News

‘Valve-in-Valve’ Technique Effective in Treating CoreValve Leaks

Jason Kahn

March 06, 2011

News Industry News

Medtronic Mosaic® Heart Valve Demonstrates Long-Term Durability Up to 12 Years in International Study

February 27, 2011

News Daily News

Different Factors Linked to Early, Late Mortality with CoreValve TAVI

L.A. McKeown

January 13, 2011

News Daily News

Consensus TAVI Endpoint Definitions Raise Standard of Research in New Field

January 11, 2011

Video

» Interview

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

April 3, 2022

Advertisement

Complications After TAVR: Manageable, But Important to Consider

TAVR Bioprosthesis Safe, Effective at 1 Year

Study Shows Medtronic CoreValve® System Efficacy and Durability Through Four Years in Longest-Term Industry Data Available

St. Jude Medical Announces FDA Approval of Trifecta Valve

TAVI with CoreValve Effective, Safe at 2-Years, Though Mortality a Concern

‘Valve-in-Valve’ Technique Effective in Treating CoreValve Leaks

Medtronic Mosaic® Heart Valve Demonstrates Long-Term Durability Up to 12 Years in International Study

Different Factors Linked to Early, Late Mortality with CoreValve TAVI

Consensus TAVI Endpoint Definitions Raise Standard of Research in New Field

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content